Inform, Member Of Austriacard Holdings company information, Employees & Contact Information

Pα+ Psychedelic Bulletin #207: Lykos Rebrands to Resilient; Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision; AbbVie-Gilgamesh Deal Viewed as Validation Psychedelic Alpha

Psychedelic drug developers redesign trials to avoid Lykos faux pas Clinical Trials Arena

Lykos’ rejection letter Politico

With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’ BioSpace

Nikolaos Lykos Buys Handful Of Shares In Austriacard Holdings simplywall.st

Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting Fierce Biotech

Elon Musk ally leads attempt to seize control of psychedelic biotech Lykos Financial Times

Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected Psychedelic Alpha

Lykos Loses Five Board Directors After FDA Rejection BioSpace

After the Lykos debacle, what’s next for psychedelic therapies? Pharmaceutical Technology

Lykos Therapeutics Restructures After FDA Setback, Commits to Progressing MDMA Therapy for PTSD AJMC

FDA staff outline shortcomings of Lykos data for MDMA therapy BioPharma Dive

Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy statnews.com

FDA gives thumbs down to MDMA for now, demanding further research NPR

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing Psychedelic Alpha

FDA rejects Lykos MDMA therapy, asks for another Phase III trial Clinical Trials Arena

Lykos to cut 75% of staff after FDA rejection of MDMA-based therapy BioPharma Dive

Following rejection and retractions, Lykos caps off chaotic week by cutting 75% of staff Fierce Biotech

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos Psychedelic Alpha

Exclusive: David Hough on Lykos’ Path to Resubmission Psychedelic Alpha

Pα+ Psychedelic Bulletin #172: Lykos Scales Back IIT Program, CEO Steps Down; Psyence Scoops Up Clairvoyant for Peanuts; Mindstate’s Moxy Enters Phase I Psychedelic Alpha

BREAKING: FDA Rejects Lykos Therapeutics’ MDMA-Assisted Therapy For PTSD Psychedelic Alpha

Pα+ Psychedelic Bulletin #199: Lykos Takeover Nears Completion; Fewer than 100 Patients Received Psychedelics in Australia During First 18 Months of Access; Ibogaine Bill Clears Texas Legislature Amid THC Crackdown Psychedelic Alpha

Lykos' MDMA treatment rejected by FDA committee, despite being '75% of the way there' Fierce Biotech

With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns Fierce Biotech

Lykos to lay off 100 employees after MDMA drug setback; founder to exit board Reuters

What Does FDA Expect from Lykos’ Next Phase 3 MDMA Study? (Part 1) Psychedelic Alpha

MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics Psychedelic Alpha

Lykos cuts 75% of staff following FDA rejection of MDMA treatment Medical Marketing and Media

FDA Releases Complete Response Letter on Declining MDMA-Assisted Therapy for PTSD Psychiatric Times

Why Lykos Therapeutics’ MDMA data had a bad trip Drug Discovery News

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated Workshop Discusses Ketamine; EMA Associates Publish Recap of Psychedelics Workshop Psychedelic Alpha

Rick Doblin, 'unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy statnews.com

Lykos CEO Steps Down In Management Shakeup lucid.news

FDA’s Lykos Rejection Delays—But Doesn’t Stop—Psychedelic Therapies BioSpace

Lykos’ MDMA-Assisted Therapy Faces Landmark Adcomm BioSpace

Lykos’ interim CEO is set to step down Endpoints News

Psychedelic biotech MAPS PBC rebrands to Lykos following FDA filing, scores $100M financing Fierce Biotech

Lykos Announces ‘Productive’ Meeting With FDA Regarding Rejected MDMA Drug BioSpace

FDA Issues CRL to Lykos for MDMA-Assisted Therapy Psychiatric Times

Lykos Therapeutics Appoints Finance Veteran Scott Giacobello to the Board of Directors PR Newswire

March & April 2025 Psychedelic Patent Update: Lykos’ Patent Woes Continue; Filings Provide First Look at Seaport’s 2-Bromo-LSD Program; Delix’s Ergoline Analogues; CaaMTech’s Spinout Psychedelic Alpha

Lykos Therapeutics Releases Statement on FDA Advisory Committee Meeting Psychiatric Times

FDA Rejects Lykos’ MDMA-Assisted PTSD Therapy After Negative Adcomm BioSpace

FDA Denies the Lykos Therapeutics Application for MDMA-Assisted Therapy lucid.news

Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals Psychedelic Alpha

Lykos accepts FDA’s view that reviving rejected MDMA therapy’s fortunes requires fresh phase 3 trial Fierce Biotech

The inside story of how Lykos’ MDMA research went awry statnews.com

MDMA Drug Developers Reprioritize Following Lykos Rejection in PTSD BioSpace

In a one-two punch for Lykos, 3 articles on MDMA treatment retracted due to unethical conduct Fierce Biotech

Lykos CEO steps down, the latest move in a string of chaotic changes Fierce Biotech

Lykos' longtime CEO to step down in latest shakeup after MDMA drug setback Reuters

FDA Adcomm Votes Against Lykos’ MDMA-Assisted PTSD Therapy BioSpace

The biggest unknown in psychedelic therapy is not the psychedelics vox.com

Lykos CEO to Resign After FDA Rejection of MDMA Therapy, Layoffs BioSpace

Peter Lykos Obituary - Chicago, IL (1927-2013) Chicago Tribune

Lykos Names Point72 Capital Markets Head McEntire as President Bloomberg.com

MDMA Papers Retracted for ‘Unethical Conduct’ on Heels of Lykos’ FDA Rejection BioSpace

MDMA therapy company Lykos raises $100M in Series A funding as it eyes FDA approval MarketWatch

Lykos Therapeutics The Pharma Letter

MDMA’s federal approval drama, briefly explained vox.com

Lykos Books Challenges Convention With Sci-Fi Debut From Physician-Turned-Author Dr. Petros Georgiou Digital Journal

The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think Slate

From Stage to Screen to Stage: Lykos makes his stand-up comedy debut at Sydney Comedy Festival Greek City Times

Lykos Metals Insiders Lose Out As Stock Sinks To AU$0.009 simplywall.st

George J. Lykos Obituary April 20, 2017 Stuhr Funeral Home

Bosnia's Lykos Balkan Metals finds gold in Jezero SeeNews

Thomas Lykos Obituary - Houston, TX Dignity Memorial

INFORM LYKOS launches the Digital Onboarding Solution in Romania business-review.eu

Antonio Gracias Leads Takeover of MDMA Therapy Firm Lykos Startup Ecosystem Canada

Irene Lykos Obituary - Houston, TX Dignity Memorial

Kafedaki with Alex Lykos - Greek City Times

Alex Lykos takes on 12 personas in his one-man play “Jawbone” Neos Kosmos

What we know about Inform P Lykos; the Greek company printing IEBC ballot papers Citizen Digital

Lykos, India’s first online refined metal retail store Trafigura

Grand jury declines to indict former District Attorney Pat Lykos Chron

Pat Lykos: The TT Interview The Texas Tribune

LYKOS LED Lights From Manfrotto ePHOTOzine